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Background. The purpose of this study was to access the eﬀects of dexmedetomidine-fentanyl infusion on blood pressure (BP)
and heart rate (HR) before surgical stimulation, on their changes to skin incision, and on isoﬂurane requirement during cardiac
surgery in children. Methods. This study had a prospective, randomized, and open-label design. Thirty-two children aged 1 month
to 10 years undergoing surgery for repair congenital heart disease (CHD) with CPB were randomly allocated into two groups:
group MDZ received midazolam 0.2mg·kg−1·h−1 and group DEX received dexmedetomidine 1μg·kg−1·h−1 during the ﬁrst hour
followed by half of these rates of infusions thereafter. Both group received fentanyl 10μg·kg−1, midazolam 0.2mg·kg−1 and
vecuronium 0.2mg·kg−1 for induction. These same doses of fentanyl and vecuronium were infused during the ﬁrst hour then
reduced to half. The infusions started after induction and maintained until the end of surgery. Isoﬂurane was given brieﬂy to
control hyperdynamic response to skin incision and sternotomy. Results. In both groups, systolic blood pressure (sBP) and heart
rate (HR) decreased signiﬁcantly after one hour of infusion of the anesthetic solutions, but there were signiﬁcantly less increase
in diastolic blood pressure, sBP, and HR, and less patients required isoﬂurane supplementation to skin incision in the patients of
the DEX group. Discussion. Dexmedetomidine infusion without a bolus appears to be an eﬀective adjunct to fentanyl anesthesia in
control of hemodynamic responses to surgery for repair of CHD in children.
1.Introduction
Midazolam (MDZ) is commonly combined with fentanyl
for pediatric congenital heart disease (CHD) in order to
provide hypnosis and deepening of the anesthetic level. This
anesthetic regimen aﬀords adequate analgesia and amnesia,
and good hemodynamic stability, even in low cardiac reserve
patients [1, 2].
Dexmedetomidine (DEX) is a highly speciﬁc and selec-
tive α2-adrenergic agonist with fast tissue distribution and
short half-life capable of inducing controllable postoperative
sedation and analgesia [3]. DEX shows superior sedation
and similar respiratory and hemodynamic eﬀects when
compared to MDZ [4]. As an adjunct to general anesthesia,
DEX decreases the anesthetic and opioid requirements in
a variety of surgical procedures [3, 5], and contrary to
MDZ, it does not increase the respiratory depressant eﬀects
of opioids [6]. In addition, DEX blunts the sympathetic-
mediated hyperdynamic response to surgical stress [5]a n d
attenuates the cardiovascular and neuroendocrine responses
to surgery in pediatric cardiac surgery patients operated on
under cardiopulmonary bypass (CPB) [7]. However, this
last ﬁnding was observed in patients more than 1 year old,
bearing relatively less complex CHD.2 Anesthesiology Research and Practice
This study compares the eﬀects of the combination of
DEX and fentanyl versus the combination of MDZ and
fentanylinfusiononbloodpressure(BP)andheartrate(HR)
before surgical stimulation, their change to skin incision
and sternotomy, and the isoﬂurane requirement to control
hyperdinamic responses in infants and children undergoing
cardiac surgery before CPB, including patients with low
cardiac reserve. We hypothesized that DEX might be an
eﬀectivesubstitutetoMDZduring fentanylanesthesia,based
on DEX capacities to provide eﬀective surgical sedation, to
potentiatetheopioidanalgesiaandtoreducethesympathetic
tone, thus buﬀering the hemodynamic response to surgical
stress.
2. Methods
After local approval and informed written consent, 32
consecutives patients undergoing elective open heart surgery
with CPB were studied. Patients with previous cardiac
surgery, metabolic, renal or hepatic disorders, prematurity,
or left ventricular hypoplasic syndrome were excluded.
Exclusion criteria also included cases where the central
venousandarterialmonitoringlinescouldnotbecannulated
within 50 minutes after induction, and those with single
ventricle physiology.
The patients were randomly allocated according to a
computer generated random list into two groups: Fentanyl
+ MDZ infusion (group MDZ, n = 16), and fentanyl +
DEX infusion (group DEX, n = 16). The study was not
blind to the surgical and anesthetic teams. All patients
had a peripheral IV line inserted preceding the anesthetic
i n d u c t i o na n dr e c e i v e dM D Z0 . 2m g ·kg−1 at or right before
being transported to the operating room (patients aged
more than 6 months). All pre-operative vasoactive drugs
infusion (dopamine, dobutamine, and PGF2) were main-
tained until the CPB was started. Anesthesia was induced
with fentanyl (10μg·kg−1) and vecuronium (0.2μg·kg−1)t o
facilitate tracheal intubation. Noninvasive BP was measured
every 2min until an artery was cannulated for continu-
ous BP measurement. All patients received promethazine
(1.0mg·kg−1), ranitidine (2.0mg·kg−1), and methylpred-
nisolone (60mg·kg−1) right after the anesthetic induc-
tion.
After intubation and placement of nasopharyngeal,
esophageal, and plantar surface temperature probes, and
once adequate noninvasive BP (every two min), heart rate
(HR), pulse oximetry (SpO2), end-tidal CO2 (ETCO2), and
electrocardiogram tracings (ECG) were obtained, the anes-
thetic combination infusion was started. The MDZ group
received an infusion of fentanyl (10μg·kg·−1h−1), MDZ
(0.2mg·kg−1·h−1), and vecuronium (0.2mg·kg·−1h−1)f o r
one hour, and the infusion rate was cut to half thereafter.
In the DEX group, this drug replaced MDZ and was
initially infused at 1.0μg·kg·−1h−1, and the infusion rate was
managed just like in the other group. The drug infusion was
mixed up in one syringe and was discontinued right before
the patients were taken to the pediatric intensive care unit
(PICU).Isoﬂurane(0.4–1%)wasbrieﬂyemployedtocontrol
20–30% preinduction level rises in BP and or HR.
The fractional inspiratory oxygen concentration (FiO2)
was kept between 0.9-1.0 and the ETCO2 between 35-
45mmHg. Positive end-expiratory pressure of 2–5cmH2O
and inspiratory/expiration ratio (I:E) of 1:1.5–1:2 were
used. The CPB was carried out at 2.5–3.0L·min−1·m2(−1) on
normothermia. The hematocrit was kept at 25% and the pH
was managed by alpha-stat strategy. Mean arterial pressure
was kept between 30 and 70mmHg. Patients were cooled
down to 26 to 32
◦C, at the surgeon’s discretions.
Ringer solution was infused at 10ml·kg−1·h−1 and
5ml·kg−1 volume challenges in order to keep the CVP
between 6–10mmHg. After CPB, albumin 5% was employed
instead. Dextrose (100mg·kg−1)w a sg i v e nf o rh yp o g l y c e m i a
(≤70mg·dl−1),butnodextrosecontainingsolutionwasoth-
erwise administered. Blood glucose levels and mixed venous
hemoglobin oxygen saturation (SvO2) were measured every
10–20minutes.OnceCPBrewarmingwasinitiated,aloading
milrinone (MIL) dose (50μg·kg−1 over 10 minutes) was
administered, followed by a 0.8μg·Kg−1·min−1 infusion
of this drug in association with a 0.03–0.2μg·kg−1·h−1
epinephrine (EPI) infusion. EPI was reduced or even dis-
continued if BP, HR, central venous pressure (CVP), heart
contractility, and SvO2 were adequate. If hypotension was
presented during EPI and MIL infusion, norepinephrine
was infused. Hypotension with normal HR and CVP was
treated with IV norepinephrine (0.03–0.1μg·kg−1·min−1).
Bradyardia associated with hypotension was managed with
an epinephrine bolus (0.1–1.0μg·kg−1) or infusion (0.03–
0.2μg·kg·min−1). Bradyardia without hypotension was
treated with atropine (30μg·kg−1). These vasoactive drugs
were used when BP and/or HR decreased to a value below
the age-adjusted expected normal values [8], or decreased
30% from baseline levels (after the initial midazolam bolus
administration). Phenylephrine (1–5μg·kg−1)w a sg i v e nt o
combat hypotension and hypoxemic crises in Tetralogy
of Fallot patients. Tachycardia not associated with the
surgicalstimuliwascontrolledwith0.5–1.0mg·kg−1 esmolol
boluses. Sodium nitroprusside (SNP) (2μg·kg−1·min·−1)
besides being infused in all patients during on CPB rewarm-
ing was used (2–8μg·kg·−1min·−1) to control systemic arte-
rial hypertension during CPB. Transient BP falls secondary
to surgical manipulation of the heart were not treated.
Preoperative cyanosis was deﬁned as sustained low
systemic arterial saturation (SpO2 ≤ 90%) requiring nasal
oxygen supplementation, during exercise, feeding, or crying
in hospital before surgery. Preoperative heart failure was
clinically determined by the pediatric cardiologist, on the
basis of echography, heart catheterization data, or treatment
with digitals and diuretics being provided within a week of
the study. Pulmonary hypertension (PH) was determined on
the preoperative echography or heart catheterization.
Hemodynamic variables (HR, BP), temperatures
(nasopharyngeal, esophageous, and plantar) were recorded
in the following time periods: after the patient was sedated
with MDZ (0.2mg·kg−1) (M-baseline values), one hour
after the anesthetic combination was initiated (1H), before
skin incision (BS), immediately after skin incision (AS),
after sternotomy (S), 10 minutes after of the sternotomy
(S10), 3–5 minutes after protamine administration (P),Anesthesiology Research and Practice 3
Table 1: Demographic, congenital heart disease (CHD), cardiopulmonary bypass (CPB), and aortic cross clamp time, and preoperative
incidence of cyanosis (C), heart failure (H), and pulmonary hypertension (P) data. Values represent individual values and mean (m) ± SD.
∗Statistical signiﬁcance, P < .05.
DEX MDZ
Pt Ag We CHD C
∗ H P Ag We CHD C H P
1 84 32 ASD + 0.7 3.3 DORV, VSD + + +
2 33 . 2 A V C , P D A + + 12 6.2 ASD, PDA + +
3 43 . 9 A V C + + 74 . 3D O R V , V S D
4 35 . 6 T O F + 44 A S D , V S D +
5 23 . 6 T A r + + + 36 14 VSD
6 12 8.3 TOF + 47 14 PVS
7 45 . 3 A S D , V S D + + 12 8 TOF +
8 76 . 3A V C , V S D + + 23 . 8 V S D +
9 0.1 3.3 TGV 8 8.2 AVC + +
10 6 6.5 AVC + + 24 9.2 AVC, ASD, VSD + +
11 7 7.2 PVS + + 108 28 SVAoS +
12 0.2 2.9 TGA, PDA + 1.4 4.3 TGV, VSD + + +
13 0.6 3.3 DORV,VSD + + 71 30 ASD
14 19 10 TOF + 7 6 TOF + +
m± 10.9 7.2 24.3 12.2
SD 20.9 7.2 20.5 8.4
Gender; M:F 6:8 8:6
CPB; min 101.9 ± 41.5 117.6 ± 44.2
Aortic cross clamp; min 71.5 ± 39.7 76.1 ± 26.7
Pt: patients; Ag: age (months), We: weight (kg); ASD: atrial septal defect, AVC: atrioventricular canal defect, DORV: double-outlet of right ventricule, IAoA:
interrupted aortic arch, PDA: patent ductus arteriosus, PVS: pulmonary valve stenosis, SVAoS: subvalvar aortic stenosis, TAr: truncus arteriosus,T G V :
transposition of the great vessels, TOF: tetralogy of Fallot, and VSD: ventricular septal defect.
and at the end of the operation (E). The intraoperative
hemodynamic (BP and HR) changes present after one
hour of the anesthetics infusion (during the period without
surgical stimulation), immediately after skin incision, and
isoﬂurane requirement to control increase 30% in BP and/or
HR from baseline levels (hyperdinamic response) before
CPB were the outcomes of primary interest.
The sample size estimation and the statistical analysis
were performed using GraphPad InStat 3.0 and GraphPad
Prism 4, respectively, (GraphPad software, San Diego, CA,
USA). To establish the sample, we took in consideration
data of BP of previous studies (1,2,7) and ﬁnding from a
performedpilotstudyasrelevantclinicalvariable.Thepower
calculation determined that the size of 14 in each group
should be suﬃc i e n tf o r8 0 %p o w e rt od e t e c tad i ﬀerence
of 20% in BP under a 5% signiﬁcance level. The Friedman
and Wilcoxon tests were used to analyze repeated measures
fromdependentvariablesandtheMann-WhitneyU-testwas
employedtocompareindependentvariablesbetweenthetwo
groups at each moment, while the demographic parameters
and adverse events were analyzed with the Fischer test. Most
of the data are shown as mean ± SD. The level of signiﬁcance
was set at P < .05.
3. Results
A total of 37 patients were invited to participate, parents of
ﬁve patients declined their children’s participation, whereas
the parents of the remaining patients approved their child
participation with an informed consent. Two neonates from
the MDZ group were excluded: one due to excessive time
to insert central venous and arterial line and the other one
because the planned surgical repair under CPB was changed
over to a systemic-to-pulmonary shunt performed oﬀ
bypass. Two neonates of the DEX group were also excluded
fromanalysisbecausetheyrequirednorepinephrinetomain-
tain BP about 20 minute of induction: one 3 days old with
IAoA receiving PGE2, dopamine, and milrinone infusions
and the other 18 days old receiving PGE2, milrinone, and
furosemide infusions. DEX infusion was continued through-
outthesurgeryinthesetwopatients.Patient’scharacteristics,
cardiac diagnoses, and CPB and aortic clamp durations are
shown in Table 1. There was a tendency to lower weight and
age in the DEX group as compared to MDZ group, but the
diﬀerence did not reach statistical signiﬁcance. Preoperative
cyanosis was signiﬁcantly more frequent in the DEX group,
and more than 50% of the patients in both groups were in4 Anesthesiology Research and Practice
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Figure 1:Eﬀectsofdexmedetomidine(DEX)onheartrate(HR)anddiastolic(dBP)andsystolicbloodpressure(sBP)duringcardiacsurgery
with CPB in children. M: after midazolan (MDZ) 0.2mg·kg−1, 1H: after one hour of infusion of DEX (1μg·kg−1)o rM D Z( 0 . 2m g ·kg−1)
associated with fentanyl (10μg·kg−1), BS: before skin incision, AS: after skin incision, E: after sternotomy, E10: 10 minutes after sternotomy.
The box represents the number of patients that required isoﬂurane after skin incision. Data represent mean ± SD. ∗Signiﬁcantly diﬀerent
from ∗M, from ∗∗BS, and ∗∗∗between groups.
congestive heart failure. PH was present in about 40% of the
patients in both groups.
ThehemodynamicvariablesaredepictedinFigure 1.The
baseline systolic blood pressure was signiﬁcantly lower in
the DEX group. HR and systolic BP decreased signiﬁcantly
after one hour of starting the test drug infusion in both
groups. In the MDZ group, all hemodynamic variables
increasedsigniﬁcantlywhentheskinincisionwasperformed.
Although a similar trend was observed in the DEX group,
it did not reach signiﬁcance. Many more patients required
isoﬂurane supplementation in the MDZ group than in the
DEX group (85.7% versus 31.2%, P = .027). Adequate HR,
BP, SvO2, and other respiratory variables were present in all
patients from both groups on arrival at the PICU.
In the DEX group, 3 patients came to the OR on
PGE2 (Prostin) and milrinone, while another one was
receiving dopamine. In the MDZ group, one patient was on
PGE2 and milrinone, and another one was on dobutamine.
Phenylephrine was used in one patient from the MDZ group
and in two patients from the DEX group. In the DEX group,
one patient was given atropine before CPB was initiated.
4. Discussion
This randomized open-label design study evaluated the
anesthetics eﬀectiveness and safety of the fentanyl and
DEX combination as compared to our routine technique in
infants and children undergoing open heart surgery underAnesthesiology Research and Practice 5
CPB, which is based on fentanyl and MDZ infusion. Both
anesthetics regimens provided eﬀective anesthesia and could
be easily supplemented by isoﬂurane to control hyperdy-
namic responses when necessary. The open label study was
recommended because the two drugs (DEX and MDZ) have
diﬀerentpharmacologicalproﬁleandtheirrespectiveadverse
eﬀects require diﬀerent management strategies. Both groups
showed similar demographics, except for a tendency towards
lower weight and age and higher incidence of cyanotic CHD
in the DEX group, which baseline systolic BP was also
lower.
The fentanyl-MDZ-based protocol, aided by isoﬂurane,
was adopted in our patient population, including infants
and children, particularly for those with low cardiac reserve,
on the basis that it has been shown to be eﬀective and
safe to providing analgesia and hypnosis with preservation
of hemodynamic stability in children undergoing open
heart surgery [2, 9, 10], although the DEX dose regimen
was investigated mostly in nonpainful procedures such as
magnetic resonance imaging [4, 11, 12], cardiac catheter-
ization [13, 14], or broncoscopy [15]. Few studies have
addressed the DEX dose regimen in children with CHD.
The study by Mukhtar et al. [7] used a dosage similar to
that recommended for normal adult patients (0.5μg·kg−1
bolus, followed by 0.5μg·kg−1·h−1 infusion) which was
eﬀective to attenuate the hemodynamic and neuroendocrine
response to surgery, without any hemodynamic deleterious
eﬀects, in patients older than 1 year, with less complex
CHD. On the other hand, Hammer et al. [16] showed
that this dosage depress the sinus rate and atrioventricular
nodal function in children undergoing electrophysiology
study. Most commonly, DEX is administered as a bolus
(0.5–1.0μg·kg−1) followed by an infusion rate of 0.2 to
2.0μg·kg−1·h−1. The loading dose may be followed by severe
hypotension, bradycardia, or sinus arrest, especially during
rapid loading, in young patients, with comorbid diseases and
on medications capable of negative chronotropic eﬀects (β-
adrenergic antagonists, and digoxin) or with reduced blood
volume [17, 18]. Since most patients of this study had these
characteristics, the loading dose was omitted in order to
avoid rapid hemodynamic changes. The 1μg·kg−1·h−1 DEX
infusion initiated immediately after induction should not
had compromised the sedation as it was gradually replacing
the MDZ (0.2mg·kg−1) sedation. This strategy of gradual
substitution of MDZ by DEX is frequently used in intensive
care unit [19, 20]. The 0.5μg·kg−1·h−1 rate has been shown
to be very eﬀective in providing sedation and analgesia
for mechanical ventilation even without any previous bolus
[21].
The primary outcomes of this study were the hemody-
namic eﬀects of the combined fentanyl and DEX infusion
as compared to our routine anesthetic technique (fentanyl
and MDZ infusion). In both experimental groups, HR and
systolic BP signiﬁcantly decreased during the one hour
period of administration before surgical stimulation was
started, but a hyperdynamic response to skin incision was
signiﬁcant only in the MDZ group, whose patients required
more isoﬂurane supplementation as well. The potentiation
of the opioid analgesia is in agreement with the well-known
DEX opioid sparing eﬀect [3]. Nevertheless, two patients
who came to the OR on PGE2 and milrinone infusion
experienced BP below acceptable levels and had to be given
norepinephrine infusion. Our results are also consistent with
other studies showing that DEX provides eﬀective sedation
and analgesia associated with hemodynamic stability and
blunts sympathetic responses during critical moments of
surgery such as skin incision and sternotomy, but can lead
to life-threatening hypotension and bradycardia requiring
prompt vasoactive support [2, 3, 7].
It is well known that fentanyl has a rapid action
onset and generates minimal hemodynamic changes even
when large doses are given in pediatric patients with very
low cardiac reserve. However, when in combination with
benzodiazepines, circulatory depression requiring volume
challenge and, in some cases, inotropic support may occur
[1, 2, 9, 19] .R i v e n e se ta l .[ 1] demonstrated that the
combinationoffentanylandMDZdepressedtheHR,BP,and
cardiac index, notwithstanding the myocardial contractility
remained the same. For this reason, in case of hemodynamic
disturbances caused by induction (fentanyl + MDZ), we
start a epinephrine, and/or norepinephrine infusion, if the
eﬀect a single dose of single dose of atropine, epinephrine
or phenylephrine and a volume challenge were not suﬃcient.
As stated above, only two patients, both in the DEX group,
required intervention to control hypotension, and this could
beduetoaninteractionofDEXwithvasodilators(milrinone
and PGE2). Whether the fentanyl and DEX combination had
compromised the cardiac output (CO) in the same intensity
as the fentanyl and MDZ combination could not be proven
in our study, despite a similar SvO2 was present at the time
recorded. It is known, however, that a DEX high infusion
rate of 0.5μg·kg−1·h−1 can reduce the CO [22]. Conversely,
DEX has been used as total intravenous anesthesia at doses
as high as 10μg·kg−1·h−1 without inducing hypotension
or severe bradycardia [15, 23]. Recently, Mason et al
[12] have shown that a DEX high dose (a bolus of 2-
3μg·kg−1 over 10 minutes, infusion of 1.5–3.0μg·kg−1·h−1)
in children undergoing MRI produces bradycardia in 16%
of these patients, but the mean arterial pressure and oxygen
saturation remained at normal range, and no adverse squeals
were observed and no speciﬁc treatment was required.
Nevertheless, children with cardiac disease were excluded
from the study and no opioid was administered. To date, this
is the ﬁrst report of the combination of anesthetics doses of
fentanyl and eﬀective sedative dose of DEX in infants and
children undergoing open heart surgery will CPB. Mukhtar
et al. study [7] involved children older than one year with
less complex CHD and used lower doses of fentanyl. The two
anesthetics regimens herein compared showed similar eﬀects
after CPB discontinuation. In fact, all patients of the two
groups arrived at the PICU with adequate hemodynamic,
respiratory function and lactate levels. Nowadays, similarly
to Easley and Tobias [24] recommendation, for children
older than one year and not receiving vasoactive support,
we start the DEX infusion soon after induction and in infant
only after obtaining central venous and arterial lines.
The potential for hypotension and systemic vasodilata-
tion due to DEX sympatholitic action carries great concern6 Anesthesiology Research and Practice
in children with cyanotic CHD, as it may increase the right-
to-left shunt thus worsening hypoxemia. Despite of having
signiﬁcant more patients with cyanotic CHD, the DEX
group showed no signiﬁcant changes in pulse oximetry as
compared to MDZ group. Possibly, fentanyl and a high FiO2
might have reduced the pulmonary vascular resistance and
oﬀsetthisdeleteriouseﬀect.Cautionshouldalsobeexercised
in patients with ﬁxed CO such as severe aortic stenosis,
since vasodilatation can lead to low coronary and cerebral
perfusion [25]. Due to the scarce experience with DEX
in pediatric patients undergoing open heart surgery or in
critical state treatment, there are yet no data concerning the
DEX eﬀects on the balance between pulmonary and systemic
vascular resistance in the single ventricle physiology; we,
therefore, excluded children undergoing Norwood, Glenn,
and Fontan surgery from our study.
Inconclusion,thecombinationoffentanyl-DEXinfusion
provided eﬀective anesthesia for pediatric patients under-
going cardiac surgery, when compared to a control group
that received fentanyl-midazolam infusion anesthesia. In
addition, the fentanyl-DEX group hyperdynamic response
to surgical stimuli was blunted. However, a worrisome
hypotensiveresponsemayensueandneedprompttreatment,
particularly in patients already receiving vasodilators.
References
[1] S. M. Rivenes, M. B. Lewin, S. A. Stayer, et al., “Cardiovascular
eﬀects of sevoﬂuorane, isoﬂuorane, halothane, and fentanyl-
midazolan in children with congenital heart disease,” Anesthe-
siology, vol. 94, pp. 223–229, 2001.
[2] E. M. Gruber, P. C. Laussen, A. Casta et al., “Stress response
in infants undergoing cardiac surgery: a randomized study
of fentanyl bolus, fentanyl infusion, and fentanyl-midazolam
infusion,”AnesthesiaandAnalgesia,vol.92,no.4,pp.882–890,
2001.
[3] A. T. Gerlach and J. F. Dasta, “Dexmedetomidine: an updated
review,” Annals of Pharmacotherapy, vol. 41, no. 2, pp. 245–
254, 2007.
[ 4 ]A .K o r o g l u ,S .D e m i r b i l e k ,H .T e k s a n ,O .S a g i r ,A .K .B u t ,
and M. O. Ersoy, “Sedative, haemodynamic and respiratory
eﬀects of dexmedetomidine in children undergoing magnetic
resonance imaging examination: preliminary results,” British
Journal of Anaesthesia, vol. 94, no. 6, pp. 821–824, 2005.
[ 5 ]C .A .M c C u t c h e o n ,R .M .O r m e ,D .A .S c o t t ,M .J .D a v i e s ,
andD.P.McGlade,“Acomparisonofdexmedetomidineversus
conventional therapy for sedation and hemodynamic control
during carotid endarterectomy performed under regional
anesthesia,” Anesthesia and Analgesia, vol. 102, no. 3, pp. 668–
675, 2006.
[6] S. R. Arain, R. M. Ruehlow, T. D. Uhrich, and T. J. Ebert, “The
eﬃcacy of dexmedetomidine versus morphine for postoper-
ative analgesia after major inpatient surgery,” Anesthesia and
Analgesia, vol. 98, no. 1, pp. 153–158, 2004.
[ 7 ]A .M .M u k h t a r ,E .M .O b a y a h ,a n dA .M .H a s s o n a ,“ T h eu s e
of dexmedetomidine in pediatric cardiac surgery,” Anesthesia
and Analgesia, vol. 103, no. 1, pp. 52–56, 2006.
[8] J.Lerman,N.Sikich,S.Kleinman,andS.Yentis,“Thepharma-
cology of sevoﬂurane in infants and children,” Anesthesiology,
vol. 80, no. 4, pp. 814–824, 1994.
[9] A. Pirat, E. Akpek, and G. Arslan, “Intrathecal versus IV fen-
tanylinpediatriccardiacanesthesia,”AnesthesiaandAnalgesia,
vol. 95, no. 5, pp. 1207–1214, 2002.
[10] T. H. Laird, S. A. Stayer, S. M. Rivenes et al., “Pulmonary-
to-systemic blood ﬂow ratio eﬀects of sevoﬂurane, isoﬂurane,
halothane,andfentanyl/midazolamwith100%oxygeninchil-
dren with congenital heart disease,” Anesthesia and Analgesia,
vol. 95, no. 5, pp. 1200–1206, 2002.
[ 1 1 ]A .K o r o g l u ,H .T e k s a n ,O .S a g i r ,A .Y u c e l ,H .I .T o p r a k ,a n d
O. M. Ersoy, “A comparison of the sedative, hemodynamic,
and respiratory eﬀects of dexmedetomidine and propofol in
children undergoing magnetic resonance imaging,” Anesthesia
and Analgesia, vol. 103, no. 1, pp. 63–67, 2006.
[12] K. P. Mason, D. Zurakowski, S. E. Zgleszewski et al., “High
dose dexmedetomidine as the sole sedative for pediatric MRI,”
Paediatric Anaesthesia, vol. 18, no. 5, pp. 403–411, 2008.
[13] Z. Tosun, A. Akin, G. Guler, A. Esmaoglu, and A. Boyaci,
“Dexmedetomidine-ketamine and propofol-ketamine combi-
nations for anesthesia in spontaneously breathing pediatric
patients undergoing cardiac catheterization,” Journal of Car-
diothoracicandVascularAnesthesia,vol.20,no.4,pp.515–519,
2006.
[14] H.M.Munro,C.F.Tirotta,D.E.Felixetal.,“Initialexperience
with dexmedetomidine for diagnostic and interventional
cardiac catheterization in children,” Paediatric Anaesthesia,
vol. 17, no. 2, pp. 109–112, 2007.
[15] M. Shukry and K. Kennedy, “Dexmedetomidine as a total
intravenous anesthetic in infants,” Paediatric Anaesthesia, vol.
17, no. 6, pp. 581–583, 2007.
[16] G. B. Hammer, D. R. Drover, H. Cao et al., “The eﬀects of
dexmedetomidine on cardiac electrophysiology in children,”
Anesthesia and Analgesia, vol. 106, no. 1, pp. 79–83, 2008.
[17] E. Deutsch and J. D. Tobias, “Hemodynamic and respiratory
changes following dexmedetomidine administration during
general anesthesia: sevoﬂurane vs desﬂurane,” Paediatric
Anaesthesia, vol. 17, no. 5, pp. 438–444, 2007.
[18] J. W. Berkenbosch and J. D. Tobias, “Development of
bradycardia during sedation with dexmedetomidine in an
infant concurrently receiving digoxin,” Pediatric Critical Care
Medicine, vol. 4, no. 2, pp. 203–205, 2003.
[19] M. Ickeringill, Y. Shehabi, H. Adamson, and U. Ruettimann,
“Dexmedetomidine infusion without loading dose in surgical
patients requiring mechanical ventilation: haemodynamic
eﬀectsandeﬃcacy,”AnaesthesiaandIntensiveCare,vol.32,no.
6, pp. 741–745, 2004.
[ 2 0 ]G .B .H a m m e r ,B .M .P h i l i p ,A .R .S c h r o e d e r ,F .S .R o s e n ,
and P. J. Koltai, “Prolonged infusion of dexmedetomidine for
sedation following tracheal resection,” Paediatric Anaesthesia,
vol. 15, no. 7, pp. 616–620, 2005.
[21] J. D. Tobias and J. W. Berkenbosch, “Sedation during mechan-
ical ventilation in infants and children: dexmedetomidine
versus midazolam,” Southern Medical Journal,v o l .9 7 ,n o .5 ,
pp. 451–455, 2004.
[ 2 2 ]Z .O z k o s e ,F .S .D e m i r ,K .P a m p a l ,a n dS .Y a r d i m ,“ H e m o -
dynamic and anesthetic advantages of dexmedetomidine, an
α2-agonist, for surgery in prone position,” Tohoku Journal
of Experimental Medicine, vol. 210, no. 2, pp. 153–160,
2006.
[23] M. A. Ramsay and D. C. Luterman, “Dexmedetomidine as
a total intravenous anesthetic agent in infants,” Pediatric
Anesthesia, vol. 17, pp. 581–583, 2007.Anesthesiology Research and Practice 7
[24] R. B. Easley and J. D. Tobias, “Pro: dexmedetomidine should
be used for infants and children undergoing cardiac surgery,”
Journal of Cardiothoracic and Vascular Anesthesia, vol. 22, no.
1, pp. 147–151, 2008.
[25] A Rosen and K. R. Rosen, “Anomalies of the aortic arch and
valve,” in Pediatric Cardiac Anesthesia,C .L .L a k ea n dP .B .
Brooker, Eds., pp. 381–424, Lippincott: Williams & Welkins,
Philadelphia, Pa, USA, 4th edition, 2005.